Data Resource Management For Human Drug Review

Ended Master BPA Awarded

Federal agency
Awardees
2
Task orders
11
Obligated
$51,317,488

Vehicle facts

Opportunity
  • FDA17SOL1179013 Solicitation number
Agency
Combined task order value
  • $51,317,488 Current, with exercised options
  • $62,738,752 Potential, with all options
Last date to order 100% complete
Shared ceiling 17% used
$300,000,000.00

IDV award and task order details come from SAM.gov/FPDS.

About this vehicle

The Food and Drug Administration established this Master BPA on October 31, 2017, to procure data resource management services for human drug review; the vehicle's ordering period closed on October 31, 2024, and is no longer available for new task orders.

The BPA has issued 11 task orders against a combined potential value of $62.7 million, with $51.3 million (82%) obligated to date. Ordering activity has been sparse and irregular—one order placed per year in 2019, 2020, and 2021, then two orders in 2023, and one in 2024. The most recent task order, awarded in June 2024, funded Over-the-Counter Monograph User Fee Program support services at $4.4 million potential value. Prior work spans data submission infrastructure (IESS 6.0), integrated data management enhancements (INTEGRITY), inventory control systems (ICIMS), knowledge management systems, and maintenance of core drug review platforms including PANORAMA and CDER systems. Task orders employ either labor-hour or time-and-materials pricing and run one to three years in duration.

Competition is highly concentrated. Booz Allen Hamilton holds 82% of awarded orders by potential value ($54.9 million across nine task orders); Octo Consulting Group holds the remaining 18% ($7.8 million across two orders). All task orders have been awarded to the Food and Drug Administration as the sole customer agency, with no subagency diversification. No task orders have been designated set-aside; all 11 orders were awarded as unrestricted competitions.

Task-order values range from approximately $2.3 million to $8.9 million in potential value. The vehicle's shared ceiling of $300 million has accommodated all awarded work comfortably, with nearly $238 million in capacity remaining, though the ordering period has expired.

IDV awards

Latest task orders

Show all 11

Top awardees by obligations

Rank Awardee Obligated Share
1 Booz Allen Hamilton Inc. $47,429,156 92%
2 Octo Consulting Group LLC $3,888,331 8%

Top funding agencies by obligations

Rank Funding agency Obligated Share
1 Department of Health and Human Services $51,317,488 100%

Obligations by fiscal year

Fiscal year Obligated
FY2025 $1,444,087
FY2024 $5,827,204
FY2023 $8,240,502
FY2022 $2,009,644
FY2021 $2,730,120
FY2020 $4,579,904
FY2019 $8,170,999
FY2018 $18,315,028

Quick answers

What is the Data Resource Management For Human Drug Review contract vehicle?

Data Resource Management For Human Drug Review is a blanket purchase agreement (BPA) vehicle run by Food and Drug Administration (Department of Health and Human Services), awarded on October 31, 2017.

Which companies hold Data Resource Management For Human Drug Review?

2 companies hold Data Resource Management For Human Drug Review's IDV awards, one each. The latest went to Booz Allen Hamilton Inc. on October 31, 2017. The awardees whose task orders obligated the most are Booz Allen Hamilton Inc. and Octo Consulting Group LLC.

How much has been spent through Data Resource Management For Human Drug Review?

11 task orders have been placed under Data Resource Management For Human Drug Review, obligating $51,317,488.

What is the shared ceiling of Data Resource Management For Human Drug Review?

Data Resource Management For Human Drug Review's shared ceiling is $300,000,000; its task orders have used 17% of it.

Which agencies use Data Resource Management For Human Drug Review the most?

The departments whose task orders under Data Resource Management For Human Drug Review obligated the most are Department of Health and Human Services ($51,317,488).

How much was obligated through Data Resource Management For Human Drug Review in fiscal year 2025?

Task orders under Data Resource Management For Human Drug Review obligated $1,444,087 in fiscal year 2025.

On GovTribe

See this vehicle's full record

  • Every IDV award and task order
  • Funding by agency, awardee, NAICS and set-aside
  • Teaming partners on this vehicle
  • Ask GovTribe AI about this vehicle